Table 3.
Data analysis of Annexin/7-AAD cytofluorimetric apoptosis assays in OVCAR8 cells.
| Samples | Early apoptosis (% ± SD) | Late apoptosis (% ± SD) | Live cells (% ± SD) |
|---|---|---|---|
| OVCAR8pc3DNA NT | 1.75 ± 0.21 | 7.55 ± 0.78 | 82.75 ± 1.20 |
| OVCAR8pc3DNA cisplatin (6 μM) | 9.85 ± 0.35 | 44.70 ± 1.13 | 42.35 ± 1.20 |
| OVCAR8pc3DNA cisplatin (6 μM)/NAC (10 mM)∗ | 5.85 ± 0.21 | 18.05 ± 0.35 | 71.70 ± 0.99 |
| OVCAR3pc3FHC cisplatin (6 μM)∗∗ | 14.25 ± 0.49 | 13.10 ± 0.42 | 71.25 ± 1.63 |
∗OVCAR8pc3DNA cisplatin (6 μM)/NAC (10 mM) vs. OVCAR8pc3DNA cisplatin (6 μM), p value < 0.05 (two-way ANOVA test). ∗∗OVCAR3pc3FHC cisplatin (6 μM) vs. OVCAR8pc3DNA cisplatin (6 μM), p value < 0.05 (two-way ANOVA test).